Vivos Stock In The News

VVOS -  USA Stock  

USD 3.55  0.13  3.53%

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Vivos and other traded companies coverage. We help investors stay connected with Vivos headlines for the 18th of October 2021 to make an informed investment decision based on correlating the impacts of news items on Vivos Stock performance. Please note that trading solely based on the Vivos Therapeutics hype is not for everyone as timely availability and quick action are needed to avoid losses.

Vivos Timeline 

 
Refresh
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Vivos Therapeutics headlines in addition to utilizing other, more conventional financial analysis modules. Also, please take a look at Vivos Therapeutics Backtesting and Vivos Therapeutics Hype Analysis.
Vivos Therapeutics' linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Vivos Therapeutics investors visualize upcoming and past events in order to time the market based on Vivos Therapeutics noise-free hype analysis.
Vivos Therapeutics stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Vivos earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
There is far too much social signal, news, headlines, and media speculation about Vivos Therapeutics that is available to investors today. That information is available publicly through Vivos media outlets and privately through word of mouth or via Vivos internal channels. However, regardless of the origin, that massive amount of Vivos data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Vivos Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Vivos Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Vivos Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Vivos Therapeutics alpha.

Vivos Largest EPS Surprises

Earnings surprises can significantly impact Vivos Therapeutics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2021-05-17
2021-03-31-0.17-0.19-0.0211 
2021-03-25
2020-12-31-0.165-0.6189-0.4539275 
View All Earnings Estimates

Vivos Therapeutics Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Vivos Therapeutics Stock. The global stock market is bullish. About 65% of major world exchanges and indexes are currently up. See today's market update for more information.
Equities News
11th of October 2021
Vivos falls 2.93 percent on Moderate Volume October 11 - Equities.com
at www.equities.com 
View Story
Equities News
28th of September 2021
Vivos falls 2.06 percent on Moderate Volume September 28 - Equities.com
at www.equities.com 
View Story
H
22nd of September 2021
Vivos Therapeutics exotic insider transaction detected
at Huntsman Ronald Kirk 
View Story
Equities News
21st of September 2021
Vivos falls 2.06 percent for September 21 - Equities.com
at www.equities.com 
View Story
Equities News
9th of September 2021
Vivos gains 5.30 percent for September 9 - Equities.com
at www.equities.com 
View Story
Macroaxis News
2nd of September 2021
Acquisition by Amman Bradford K of 83334 shares of Vivos Therapeutics subject to Rule 16b-...
at MacroaxisInsider 
View Story
Yahoo News
23rd of August 2021
Why Xeris Pharmaceuticals Shares Traded Higher Today - Yahoo Finance
at finance.yahoo.com 
View Story
Macroaxis News
18th of August 2021
Vivos Therapeutics exotic insider transaction detected
at MacroaxisInsider 
View Story
E
12th of August 2021
EPS Reported
at EPS REPORTED 
View Story
Equities News
11th of August 2021
Vivos gains 0.71 percent for August 11 - Equities.com
at www.equities.com 
View Story
G
10th of August 2021
Acquisition by Green Ralph Elias of 30000 shares of Vivos Therapeutics subject to Rule 16b...
at Green Ralph Elias 
View Story
Equities News
30th of July 2021
Vivos falls 3.21 percent on Moderate Volume July 30 - Equities.com
at www.equities.com 
View Story

Vivos Therapeutics Investors Sentiment

The influence of Vivos Therapeutics' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Vivos. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.

Current Sentiment - VVOS

Vivos Therapeutics Investor Sentiment

Macroaxis portfolio users are unemotional in their outlook on investing in Vivos Therapeutics. What is your outlook on investing in Vivos Therapeutics? Are you bullish or bearish?
Bullish
Bearish
50% Bullish
50% Bearish
Skip

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity..
Also, please take a look at Vivos Therapeutics Backtesting and Vivos Therapeutics Hype Analysis. Note that the Vivos Therapeutics information on this page should be used as a complementary analysis to other Vivos Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Complementary Tools for Vivos Stock analysis

When running Vivos Therapeutics price analysis, check to measure Vivos Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vivos Therapeutics is operating at the current time. Most of Vivos Therapeutics' value examination focuses on studying past and present price action to predict the probability of Vivos Therapeutics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Vivos Therapeutics' price. Additionally, you may evaluate how the addition of Vivos Therapeutics to your portfolios can decrease your overall portfolio volatility.
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
The market value of Vivos Therapeutics is measured differently than its book value, which is the value of Vivos that is recorded on the company's balance sheet. Investors also form their own opinion of Vivos Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Vivos Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vivos Therapeutics' market value can be influenced by many factors that don't directly affect Vivos Therapeutics underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vivos Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine Vivos Therapeutics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vivos Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.